AbbottPharmaLong
Long Term breakout failed due to news flow but stock is strong to bounce back
Strong fundamentals and healthy balance sheet
Big player in domestic pharma brands
Buy for long term targets of 26k+ in year
Strong fundamentals and healthy balance sheet
Big player in domestic pharma brands
Buy for long term targets of 26k+ in year
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.